Evidence map›Paper›PMID 29051427›Full record

ReviewToxics2016

Developmental Bisphenol A Exposure Modulates Immune-Related Diseases.

Joella Xu, Guannan Huang, Tai L Guo

Open access · goldAbstract readReview
In one paragraph

Review in Toxics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The influence of endocrine disruptors on the gut microbiota.Turkish journal of medical sciences · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens.International journal of environmental research and public health · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joella XuDepartment of Veterinary Biosciences and Diagnostic Imaging, Interdisciplinary Toxicology Program, University of Georgia, Athens, GA 30602-7382, USA. joella@uga.edu.
Guannan HuangDepartment of Environmental Health Sciences, University of Georgia, Athens, GA 30602-7382, USA. guhuang@uga.edu.
Tai L GuoDepartment of Veterinary Biosciences and Diagnostic Imaging, Interdisciplinary Toxicology Program, University of Georgia, Athens, GA 30602-7382, USA. tlguo1@uga.edu.
University of Georgia · US

Funding

Exacerbation of type 1 diabetes in mice by bisphenol A and genisteinR21ES024487 · NIEHS · UNIVERSITY OF GEORGIA · PI GUO, TAI L · 2014 to 2015
$411k
NIEHS NIH HHS R21 ES024487
6 · The paper itself

Abstract

Bisphenol A (BPA), used in polycarbonate plastics and epoxy resins, has a widespread exposure to humans. BPA is of concern for developmental exposure resulting in immunomodulation and disease development due to its ability to cross the placental barrier and presence in breast milk. BPA can use various mechanisms to modulate the immune system and affect diseases, including agonistic and antagonistic effects on many receptors (e.g., estrogen receptors), epigenetic modifications, acting on cell signaling pathways and, likely, the gut microbiome. Immune cell populations and function from the innate and adaptive immune system are altered by developmental BPA exposure, including decreased T regulatory (Treg) cells and upregulated pro- and anti-inflammatory cytokines and chemokines. Developmental BPA exposure can also contribute to the development of type 2 diabetes mellitus, allergy, asthma and mammary cancer disease by altering immune function. Multiple sclerosis and type 1 diabetes mellitus may also be exacerbated by BPA, although more research is needed. Additionally, BPA analogs, such as bisphenol S (BPS), have been increasing in use, and currently, little is known about their immune effects. Therefore, more studies should be conducted to determine if developmental exposure BPA and its analogs modulate immune responses and lead to immune-related diseases.

Indexed as

allergyasthmabisphenol Abisphenol Sdevelopmentaldiabetesepigeneticsimmunotoxicitymammary cancermicrobiomemultiple sclerosis

Identifiers

PMID29051427
PMCPMC5606650
OpenAlexW2527243083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.